Structural Design of Micro-and Nano-gel Particles for Appropriate Controlled Release of Peptide Drugs
用于适当控制释放肽类药物的微米和纳米凝胶颗粒的结构设计
基本信息
- 批准号:16590038
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The aim of the present research project is to develop nano-and micro-particulate systems with appropriate controlled release functions for peptide drug delivery. The proposed systems are directed to long-term delayed release for peroral colon-specific peptide delivery, externally temperature-activated periodically pulsatile release for chronopharmacological peptide delivery, and pH-dependent prolonged release using thermo-and pH-sensitive nanogels for oral peptide delivery. The results obtained are summarized as follows :1. The microcapsules composed of a lactose core, an insulin-layer and a coat of newly synthesized acrylic terpolymer made it possible to achieve a pH-independent delayed-release characterized by a lag-time and subsequent rapid insulin release. The microencapsulated insulin was found to be stable even after the storage at 4℃ for 24 months. In vivo oral administration studies of the microcapsules with a lag-time of 6h revealed a significant hypoglycemic effect, indicatin … More g insulin absorption through the colon. The pharmacological availability reached 5.1%.2. The microcapsules having an ability to thermosensitively control the drug-release could be achieved by fabricating an ethylcellulose matrix coat containing nano-sized p(NIPAAm) hydrogels onto a drug-layered core. Introduction of poly(□-caprolactone) macromer into p(NIPAAm) nanogels or use of hydroxypropylcellulose as an alternative thermosensitively component was useful to achieve distinct thermosensitive periodical pulsatile release.3. The nanogels composed of thermosensitive p(NIPAAm) core and pH sensitive (MAA-g-EG) shells (CSNPs) for oral peptide delivery were characterized in terms of drug loading capacity and muco-adhesive properties. Newly established drug-loading method was useful to significantly increase drug content (20 wt%). Atomic force microscopy (AFM) using colloidal probe of CSNPs for analyzing particle-mucin layer interaction could also be established : pH-dependent changes of interaction force were observed between CSNPs and mucin layer.4. As a solvent-free preparation process, dry-powder coating technique could be established. This technology is expected to process moisture-sensitive peptide-drug stably in an aseptic condition. Less
本研究的目的是开发具有适当控制释放功能的纳米和微米微粒系统用于肽药物递送。所提出的系统涉及用于经口结肠特异性肽递送的长期延迟释放、用于时间药理学肽递送的外部温度激活的周期性脉冲释放以及用于经口肽递送的使用热和pH敏感性纳米凝胶的pH依赖性延长释放。主要研究结果如下:1.微囊由乳糖芯、胰岛素层和新合成的丙烯酸酯涂层组成,使得能够实现以滞后时间和随后的快速胰岛素释放为特征的pH非依赖性延迟释放。微囊化胰岛素在4℃下储存24个月后仍保持稳定。体内口服给药研究表明,该微囊具有显著的降血糖作用, ...更多信息 g胰岛素通过结肠吸收。药理利用度为5.1%。具有热敏控制药物释放能力的微囊可以通过在药物层芯上制备含有纳米级p(NIPAAm)水凝胶的乙基纤维素基质包衣来实现。在p(NIPAAm)纳米凝胶中引入聚(□-己内酯)大分子单体或使用羟丙基纤维素作为替代热敏组分可用于实现明显的热敏周期性脉冲释放.制备了以p(NIPAAm)为核、pH敏感(MAA-g-EG)为壳的纳米凝胶(CSNPs),考察了其载药量和粘膜粘附性能。新建立的载药方法有助于显着提高药物含量(20 wt%)。利用CSNPs胶体探针的原子力显微镜(AFM)分析颗粒与粘蛋白层的相互作用,观察到CSNPs与粘蛋白层之间的相互作用力随pH值的变化.作为一种无溶剂制备工艺,干粉包衣技术可以建立。该技术有望在无菌条件下稳定地处理对水分敏感的肽-药物。少
项目成果
期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ナノパーティクルテクノロジーハンドブック
纳米粒子技术手册
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:下間靖彦;邱 建栄;三浦清貴;平尾一之(分担執筆);平尾一之(分担執筆)
- 通讯作者:平尾一之(分担執筆)
Powder Technology Handbook
- DOI:10.1201/b22268
- 发表时间:2019-08
- 期刊:
- 影响因子:0
- 作者:K. Higashitani;H. Makino;S. Matsusaka
- 通讯作者:K. Higashitani;H. Makino;S. Matsusaka
MML Series Volume 8, Smart Nanoparticles in Nanomedicine
MML 系列第 8 卷,纳米医学中的智能纳米颗粒
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:H.Ichikawa;Y.Fukumori
- 通讯作者:Y.Fukumori
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ICHIKAWA Hideki其他文献
ICHIKAWA Hideki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ICHIKAWA Hideki', 18)}}的其他基金
Development of Microencapsulated Peptide Drugs with Specific Controlled Release Functions by Air Suspension Coating Process
空气悬浮包衣工艺开发具有特定控释功能的微囊化多肽药物
- 批准号:
12672098 - 财政年份:2000
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Time-dependent controlled release of multiple drugs to accelerate the regeneration of soft and hard tissue using nanofibrous guided bone regeneration membrane
利用纳米纤维引导骨再生膜,时间依赖性控制释放多种药物,加速软硬组织再生
- 批准号:
23K16040 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Unlocking the Potential of Active Lipid Vesicles for Directed Delivery and Controlled Release of Therapeutic Payloads
合作研究:释放活性脂质囊泡用于治疗有效负载的定向递送和受控释放的潜力
- 批准号:
2323046 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Standard Grant
Collaborative Research: Unlocking the Potential of Active Lipid Vesicles for Directed Delivery and Controlled Release of Therapeutic Payloads
合作研究:释放活性脂质囊泡用于治疗有效负载的定向递送和受控释放的潜力
- 批准号:
2323045 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Standard Grant
Controlled-release Microbeads to Replace Growth Factors in Fetal Bovine Serum
控释微珠替代胎牛血清中的生长因子
- 批准号:
10596894 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Antibacterial and Antithrombotic Catheter Lock Solutions Based on Controlled Release of Nitric Oxide
基于一氧化氮控制释放的抗菌和抗血栓导管锁解决方案
- 批准号:
10634183 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Developing controlled release immune complexes to treat multiple sclerosis
开发控释免疫复合物来治疗多发性硬化症
- 批准号:
10679346 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Bio-inspired nanomaterials with tunable drug loading and controlled release
具有可调节药物负载和控制释放的仿生纳米材料
- 批准号:
DE230101044 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Discovery Early Career Researcher Award
Preclinical optimisation and evaluation of controlled release ophthalmic depots for anti-VEGF treatments: readiness for Pharma partnering
用于抗 VEGF 治疗的控释眼科长效制剂的临床前优化和评估:为制药合作做好准备
- 批准号:
10027309 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Collaborative R&D
Metal-organic Frameworks as Controlled Release Materials
金属有机框架作为控释材料
- 批准号:
RGPIN-2020-04570 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Discovery Grants Program - Individual
A New Spin on Affinity for Controlled Release: Orthogonal Release of Multiple Factors Through Directed Evolution
控制释放亲和力的新旋转:通过定向进化正交释放多个因子
- 批准号:
547181-2020 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Postgraduate Scholarships - Doctoral